CORRECTED-Obagi Medical gets higher offer from Merz Pharma
(Corrects paragraph 1 to say Obagi is a cosmetic products maker, not a laser device maker)
April 2 (Reuters) - Neurological and dermatology drugs maker Merz Pharma Group offered to buy cosmetic products maker Obagi Medical Products Inc for $383.5 million, topping a bid by Canada's Valeant Pharmaceuticals International Inc last month.
Merz's offer of $22 per share represents a premium of 11 percent to Valeant's offer of $19.75. (Reporting by Esha Dey in Bangalore; Editing by Saumyadeb Chakrabarty)